OMX Nordic 40
2.437,72
PKT
+25,37
PKT
+1,05
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.02.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 07.02.17 | Nokia overweight | Morgan Stanley | |
| 06.02.17 | AstraZeneca buy | Deutsche Bank AG | |
| 06.02.17 | Novo Nordisk verkaufen | JP Morgan Chase & Co. | |
| 06.02.17 | Novo Nordisk Hold | HSBC | |
| 03.02.17 | Nokia buy | S&P Capital IQ | |
| 03.02.17 | Volvo (B) buy | Jefferies & Company Inc. | |
| 03.02.17 | Nokia buy | Deutsche Bank AG | |
| 03.02.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 03.02.17 | Novo Nordisk buy | UBS AG | |
| 03.02.17 | Nokia buy | UBS AG | |
| 03.02.17 | Nokia overweight | JP Morgan Chase & Co. | |
| 03.02.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 03.02.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 03.02.17 | Novo Nordisk Neutral | Citigroup Corp. | |
| 03.02.17 | Nokia buy | Goldman Sachs Group Inc. | |
| 03.02.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 03.02.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 02.02.17 | AstraZeneca buy | UBS AG | |
| 02.02.17 | Nokia Equal-Weight | Morgan Stanley | |
| 02.02.17 | Nokia buy | Kepler Cheuvreux | |
| 02.02.17 | Volvo (B) Underweight | Barclays Capital | |
| 02.02.17 | Volvo (B) buy | Citigroup Corp. | |
| 02.02.17 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 01.02.17 | Volvo (B) Hold | S&P Capital IQ | |
| 30.01.17 | Nokia overweight | JP Morgan Chase & Co. | |
| 30.01.17 | AstraZeneca buy | Jefferies & Company Inc. | |
| 30.01.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 27.01.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 27.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Deutsche Bank AG | |
| 27.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Equal-Weight | Morgan Stanley | |
| 27.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Sell | Goldman Sachs Group Inc. | |
| 27.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
| 27.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 27.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Hold | S&P Capital IQ | |
| 26.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Equal weight | Barclays Capital | |
| 26.01.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 26.01.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 24.01.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
| 24.01.17 | Novo Nordisk buy | Goldman Sachs Group Inc. |